Multiple myeloma
Last updated 18 Sept 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. The bone marrow produces red blood cells, which carry oxygen throughout the body; white blood cells, which form the body's defenses (immune system); and platelets, which are necessary for blood clotting.
Video picks for Genetic conditionsVideo library
Description
Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. The bone marrow produces red blood cells, which carry oxygen throughout the body; white blood cells, which form the body's defenses (immune system); and platelets, which are necessary for blood clotting.
Multiple myeloma is characterised by abnormalities in plasma cells, a type of white blood cell. These abnormal cells multiply out of control, increasing from about one percent of cells in the bone marrow to the majority of bone marrow cells. The abnormal cells form tumours within the bone, causing bone pain and an increased risk of fractures. If the tumours interfere with nerves near the bones, numbness or weakness in the arms or legs can occur. Affected individuals may also experience a loss of bone tissue, particularly in the skull, spine, ribs, and pelvis. The deterioration of bone can result in an excess of calcium in the blood (hypercalcemia), which can lead to nausea and loss of appetite, excessive thirst, fatigue, muscle weakness, and confusion.
The abnormal plasma cells in multiple myeloma produce proteins that impair the development of normal blood cells. As a result, affected individuals may have a reduced number of red blood cells (anaemia), which can cause fatigue, weakness, and unusually pale skin (pallor); a low number of white blood cells (leukopenia), which can result in a weakened immune system and frequent infections such as pneumonia; and a reduced number of platelets (thrombocytopenia), which can lead to abnormal bleeding and bruising. Kidney problems can also occur in this disorder, caused by hypercalcemia or by toxic proteins produced by the abnormal plasma cells.
People with multiple myeloma typically develop the disorder around age 65. Over time, affected individuals can develop life-threatening complications, but the rate at which this happens varies widely. Some affected individuals are diagnosed incidentally when tests are done for other purposes and do not experience symptoms for years.
Inheritance patterns
The source lists the following possible inheritance patterns: Not inherited; Pattern unknown. More than one pattern can apply in different cases.
Related genes
Other names
Kahler disease
Kahler's disease
Kahler-Bozzolo disease
Medullary plasmacytoma
Myelomatosis
Plasma cell dyscrasia
Plasma cell myelomas
Patient picks for Genetic conditions

Cancer
Myeloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. As the cancerous plasma cells fill the bone marrow, you are not able to make enough normal blood cells. This can lead to anaemia, bleeding problems and infections. Other symptoms include bone pain, breaks (fractures) due to bone damage, and kidney damage. In many cases, treatment with chemotherapy and other treatments can control the disease, ease symptoms and prolong survival for a number of years.
by Dr Colin Tidy, MRCGP

Brain and nerves
Multiple sclerosis
Multiple sclerosis is a disorder of the brain and spinal cord. It can cause various symptoms. In most cases, episodes of symptoms come and go for several years. In time, some symptoms can become permanent and can cause disability. Although there is no cure for multiple sclerosis, various medicines and therapies may reduce the number of flare-ups and can help to ease symptoms and disability.
by Dr Hayley Willacy, FRCGP

Pregnancy
Multiple pregnancy
In a multiple pregnancy, there is more than one baby growing in the womb (uterus) at the same time. Being pregnant with twins is the most common example. Both mother and babies need extra monitoring during pregnancy as the risks are higher than in a singleton pregnancy.
by Dr Toni Hazell, FRCGP
Preventative health
Down Dog Stretch
The Down Dog Stretch has numerous benefits for your body. It primarily stretches and strengthens multiple muscle groups simultaneously, including the shoulders, hamstrings, calves, and the entire back body.
Lower body strength & conditioning exercises
Switch Kick
Switch Kicks are a dynamic and engaging exercise designed to elevate your Lower Body strength and agility. In this exercise, you'll perform alternating kicks, engaging your core, legs, and cardio fitness. Challenge your coordination and balance while building strength in your legs. This exercise targets multiple muscle groups and keeps you moving.
Workplace & corporate wellbeing
Seated Forward Punch Toe Tap Combo
This exercise is effective for targeting multiple muscle groups and improving overall body coordination while seated.
Related patient information and medicines

Patient information leaflet
Myeloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Myeloma is a type of blood cancer. Dr Krishna Vakharia , 10th April 2025 The National Institute for Health and Care Excellence (NICE) has updated its guidance on assessment for myeloma in all ages including those under 60 years of age if they have persistent bone.

Patient information leaflet
Proteinuria
Multiple myeloma Myeloma , a type of cancer. Other conditions that affect the filtering part of the... For example, some types of multiple myeloma produce very high levels of a specific protein - called free light chains - which can spill over into the urine if blood levels get too high. People with complex diseases which may involve the kidneys -.

Patient information leaflet
The immune system
This leaflet gives a brief overview of the immune system and how it works. A person with a weak immune system might have difficulty fighting off infections. Some disorders of the immune system include: HIV and AIDS HIV and AIDs - when your immune system is weakened. Lymphoma Non-Hodgkin's lymphoma , myeloma Myeloma and leukaemia Leukaemia -.

Patient information leaflet
Hyponatraemia
Diseases of the liver such as fibrosis or cirrhosis. Kidney failure. Falsely low sodium levels Very high cholesterol levels. Very high blood sugar levels. Too much protein in the blood, sometimes caused by a cancer called multiple myeloma. In these cases the result for the blood sodium will be low but the actual blood sodium level is normal. Who's.

Patient information leaflet
Immunosuppression
Cancers. Certain cancers can cause immune suppression, particularly those which involve the blood cells crucial to the immune system. Lymphomas, leukaemias and myeloma Myeloma are the cancers which tend to suppress the immune system. Not having a spleen Spleen pain , due to its having been removed (splenectomy) or having a spleen which does not.

Patient information leaflet
Stem cell transplant
A stem cell transplant is where blood stem cells (the cells produced by the bone marrow to turn into different types of blood cells) are put back into your body when your bone marrow has been destroyed... A stem cell transplant is an option which is considered for various cancer conditions, especially blood cancers Cancer. Lymphoma ( Hodgkin's.
Further reading and references
- Multiple myeloma; MedlinePlus, National Library of Medicine.
- Bataille R. The multiple myeloma bone eco-system and its relation to oncogenesis. Morphologie. 2015 Jun;99(325):31-7. doi: 10.1016/j.morpho.2015.03.002. Epub 2015 May 23.
- Bianchi G, Anderson KC. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back. CA Cancer J Clin. 2014 Nov-Dec;64(6):422-44. doi: 10.3322/caac.21252. Epub 2014 Sep 29.
- Martino A, Campa D, Jurczyszyn A, Martinez-Lopez J, Moreno MJ, Varkonyi J, Dumontet C, Garcia-Sanz R, Gemignani F, Jamroziak K, Stepiel A, Jacobsen SE, Andersen V, Jurado M, Landi S, Rossi AM, Lesueur F, Marques H, Dudzinski M, Watek M, Moreno V, Orciuolo E, Petrini M, Reis RM, Rios R, Sainz J, Vogel U, Buda G, Vangsted AJ, Canzian F. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):670-4. doi: 10.1158/1055-9965.EPI-13-1115. Epub 2014 Feb 12.
- Munshi NC, Avet-Loiseau H. Genomics in multiple myeloma. Clin Cancer Res. 2011 Mar 15;17(6):1234-42. doi: 10.1158/1078-0432.CCR-10-1843.
- NCI Surveillance, Epidemiology, and End Results Program
- Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015 May 30;385(9983):2197-208. doi: 10.1016/S0140-6736(14)60493-1. Epub 2014 Dec 23.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

